- Home
- ES vs BNTX Comparison
ES vs BNTX Comparison
Compare ES & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ES | BNTX |
|---|---|---|
| Founded | 1927 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.7B | 24.8B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | ES | BNTX |
|---|---|---|
| Price | $67.60 | $92.51 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 11 |
| Target Price | $70.83 | ★ $137.40 |
| AVG Volume (30 Days) | ★ 2.7M | 1.5M |
| Earning Date | 02-10-2026 | 11-03-2025 |
| Dividend Yield | ★ 4.48% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 3.65 | N/A |
| Revenue | ★ $13,148,536,000.00 | $3,698,814,972.00 |
| Revenue This Year | $10.10 | $2.36 |
| Revenue Next Year | $4.11 | N/A |
| P/E Ratio | $18.42 | ★ N/A |
| Revenue Growth | ★ 13.12 | 3.70 |
| 52 Week Low | $52.28 | $81.20 |
| 52 Week High | $75.25 | $129.27 |
Technical Indicators
Market Signals| Indicator | ES | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 45.10 | 35.58 |
| Support Level | $66.73 | $91.11 |
| Resistance Level | $68.18 | $93.76 |
| Average True Range (ATR) | 1.13 | 2.08 |
| MACD | 0.26 | -0.33 |
| Stochastic Oscillator | 58.36 | 15.27 |
Price Performance
Historical ComparisonAbout ES Eversource Energy (D/B/A)
Eversource Energy is a diversified holding company with subsidiaries that provide rate-regulated electric and gas distribution service to more than 4 million customers in the Northeast US. Eversource expanded its service territories with acquisitions of NStar (2012), Aquarion (2017), and Columbia Gas (2020). In 2024 Eversource exited its 50% partnership with European utility Orsted to develop 2 gigawatts of offshore wind projects in the Northeast US. The company exited most of its unregulated businesses in 2006.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.